FDA Panel Rejects AstraZeneca Drug
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.
78604
A US Food and Drug Administration official said Friday &quot;we categorically reject&quot; accusations the agency has failed to protect the public against dangerous drugs.
123821
WASHINGTON A US Food and Drug Administration official on Friday &quot;categorically&quot; rejected accusations that the agency had failed to protect the public against dangerous drugs, especially Merck&#39;s Vioxx painkiller.
594386
GAITHERSBURG, Maryland  - A U.S. advisory panel on   Thursday rejected a Food and Drug Administration report that   concluded there was no evidence that silver dental fillings   made with mercury cause serious harm to humans.
161543
Shares in pharmaceutical giants AstraZeneca PLC and GlaxoSmithKline PLC tumbled Friday after a US safety official raised concerns over key drugs sold by the companies.
442644
AstraZeneca Plc has withdrawn its marketing application for lung cancer pill Iressa in Europe after the drug failed to help patients live longer in a clinical study, Europe's third largest drugmaker said on Tuesday.
410890
AstraZeneca shares have fallen more than 6 percent after a US medical panel recommended regulators reject its anti-clotting pill Exanta, a key product for the company&#39;s future growth.
691286
Drug maker AstraZeneca PLC said Friday that the Food and Drug Administration did not approve its orally taken blood thinner Exanta.
115547
AstraZeneca Plc's experimental cancer  drug AZD2281 has been given orphan drug status by the European  Medicines Agency for treating women with ovarian cancer,  Britain's second biggest drugmaker said on Tuesday.
501618
Federal health advisers unanimously rejected a weight-loss drug Wednesday after hearing testimony that it increases the risk of suicidal thoughts, even in patients without a history of depression. The manufacturer, Sanofi-Aventis SA, further failed to show the drug rimonabant is safe, the panel said.
460971
Will AstraZeneca become the latest casualty in the drug safety debate?
579894
Twenty-nine patients who took AstraZeneca Plc's  cholesterol drug Crestor have developed kidney damage, a U.S. consumer group said on Friday as it called again for a ban on the medicine.
188931
The doctor rejected his staff&#39;s assessment that Uganda site was not qualified to continue drug research. By John Solomon. WASHINGTON -- The government&#39;s chief of AIDS research rewrote a safety report on a US
45410
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down as much as 9.2 percent.
671791
Federal regulators did not act on a recommendation from their safety reviewers about the risk of heart attacks for the diabetes drug Avandia.
215621
The U.S. Food and Drug Administration  said on Friday that Senate testimony by a veteran FDA  researcher regarding safety risks for five drugs does not  reflect the views of the agency.